Literature DB >> 32562941

Porous Pt nanoparticles loaded with doxorubicin to enable synergistic Chemo-/Electrodynamic Therapy.

Tong Chen1, Tongxu Gu1, Liang Cheng2, Xiang Li3, Gaorong Han1, Zhuang Liu4.   

Abstract

Overexpression of P-glycoprotein (P-gp), which is responsible for pumping chemotherapeutic drugs out of tumor cells, has been recognized as an important cause of drug resistance in conventional chemotherapy. Herein, porous platinum nanoparticles (pPt NPs) are developed to enable the combined electrodynamic therapy (EDT) with chemotherapy. With polyethylene glycol (PEG) coating, the obtained pPt-PEG NPs could be loaded with anticancer drug doxorubicin (DOX) by utilizing the porous structure of pPt NPs. Those pPt-PEG NPs are able to produce reactive oxygen species (ROS) by triggering water decomposition under electric field, independent of O2 and H2O2 contents in the tumor. Furthermore, the ROS generated during EDT could induce the inhibition of P-glycoprotein (P-gp), in turn enhancing the efficacy of chemotherapeutic agents by facilitating intracellular accumulation of drugs. As the results, excellent synergetic therapeutic effects were observed by combining chemotherapy with EDT using DOX-loaded pPt (DOX@pPt-PEG) NPs, as demonstrated by both in vitro and in vivo experiments. This study demonstrates a new concept of combinational cancer therapy with superior therapeutic efficacy.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Chemotherapy; Electrodynamic therapy; P-Glycoprotein; Porous platinum nanoparticles

Mesh:

Substances:

Year:  2020        PMID: 32562941     DOI: 10.1016/j.biomaterials.2020.120202

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  6 in total

1.  Platinum-copper alloy nanoparticles armored with chloride ion transporter to promote electro-driven tumor inhibition.

Authors:  Tong Chen; Gaorong Han; Xiang Li
Journal:  Bioact Mater       Date:  2021-10-13

Review 2.  Platinum-based drugs for cancer therapy and anti-tumor strategies.

Authors:  Chunyu Zhang; Chao Xu; Xueyun Gao; Qingqiang Yao
Journal:  Theranostics       Date:  2022-02-07       Impact factor: 11.556

3.  Metal Cluster Triggered-Assembling Heterogeneous Au-Ag Nanoclusters with Highly Loading Performance and Biocompatible Capability.

Authors:  Xiaoxiao He; Xiaohong Ma; Yujun Yang; Xi Hu; Teng Wang; Shiyue Chen; Xiang Mao
Journal:  Int J Mol Sci       Date:  2022-09-23       Impact factor: 6.208

4.  K. ZHENG ET AL.Gold-nanoparticle-based multistage drug delivery system for antitumor therapy.

Authors:  Kaikai Zheng; Dong Zhou; Lili Wu; Jian Li; Bing Zhao; Shihao Zhang; Ruiying He; Lan Xiao; Iqbal Zoya; Li Yu; Yuhong Zhang; Yulin Li; Jie Gao; Kaichun Li
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

5.  Fe3O4@Pt nanoparticles to enable combinational electrodynamic/chemodynamic therapy.

Authors:  Tong Chen; Qiang Chu; Mengyang Li; Gaorong Han; Xiang Li
Journal:  J Nanobiotechnology       Date:  2021-07-10       Impact factor: 10.435

6.  Cu-Ferrocene-Functionalized CaO2 Nanoparticles to Enable Tumor-Specific Synergistic Therapy with GSH Depletion and Calcium Overload.

Authors:  Hanjing Kong; Qiang Chu; Chao Fang; Guodong Cao; Gaorong Han; Xiang Li
Journal:  Adv Sci (Weinh)       Date:  2021-05-24       Impact factor: 16.806

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.